CardiaTec Biosciences
Decoding cardiovascular disease with AI
Munich, United Kingdom · $8.2M raised
- Headquarters
- Munich
- Business Model
- B2B
- Website
- cardiatec.ai
- Total Funding
- $8.2M
- Last Round
- $6.5M SeedSep 2024
- Rounds
- 2
About
CardiaTec is a TechBio company leveraging multiomics data from human cardiac tissue to discover novel cardiovascular therapeutics. The company builds the largest human cardiac tissue multiomics database through partnerships with 65+ hospitals across the US and UK, using advanced computational modeling and AI to unravel disease mechanisms and discover drug targets.
Summary
CardiaTec Biosciences is a Healthcare company based in Munich, United Kingdom. It has raised $8.2M in total across 2 rounds, most recently a $6.5M Seed round in Sep 2024. Investors include Montage Ventures, Laidlaw Scholars Ventures and APEX Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...